Clinical Trials Directory

Trials / Completed

CompletedNCT03543917

Post-Stroke Improvement of Motor Function

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
17 (actual)
Sponsor
Fundatia Bio-Forum · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Open-label clinical study where all new patients presenting with cerebrovascular accidents and consenting to treatment are given intravenously a new combination of medications. Patients are evaluated neurologically with NIHSS scores before treatment administration and at 1 month after the first treatment. Further evaluations at 6 months after treatment by NIHSS and Barthel scores are ongoing

Detailed description

Patients with cerebrovascular accidents (CVA), ischemic (including those with hemorrhagic transformation), are given a new combination of medications which aims to improve neuronal survival, stimulate mitochondrial genesis and the formation of new synapses. This combination is given as an intravenous perfusion with a 2-hr duration and consists of vitamins B1, B6, B12, C, Actovegin, etc. Before treatment a NIHSS score is given. Each patient receives 3-4 such perfusions in 1 month and afterwards another NIHSS score is obtained. Patients are monitored afterwards and those who show improvements receive more such treatments, and new NIHSS and Barthel scores are obtained. Patients are grouped on the basis of the time interval between CVA occurence and first treatment: * Group 1: 0-35 days * Group 2: 36-100 days * Group 3: 101-360 days Improvement of motor function is compared using NIHSS scores between groups, and between literature and groups

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTPerfusion with New Combination MedicationIntravenous administration of Actovegin, vitamins B1, B6, B12, C, oxytocin/dexamethasone, calcium gluconate, etc in 250 ml normal saline administered during approximately 2 hours

Timeline

Start date
2017-08-08
Primary completion
2018-08-30
Completion
2018-09-29
First posted
2018-06-01
Last updated
2018-11-19

Locations

1 site across 1 country: Romania

Source: ClinicalTrials.gov record NCT03543917. Inclusion in this directory is not an endorsement.